Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study.
Arrieta O, Martinez-Barrera L, Treviño S, Guzman E, Castillo-Gonzalez P, Rios-Trejo MA, Flores-Estrada D, Téllez E, Gonzalez C, de la Cruz Vargas J, Gonzalez-De la Rosa CH, Hernandez-Pedro N, Morales-Barrera R, De la Garza J. Arrieta O, et al. Among authors: de la garza j, de la cruz vargas j. J Thorac Oncol. 2008 Aug;3(8):887-93. doi: 10.1097/JTO.0b013e31818026f6. J Thorac Oncol. 2008. PMID: 18670307 Free article. Clinical Trial.
Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).
Arrieta O, Maldonado F, Turcott JG, Zatarain-Barrón ZL, Barrón F, Blake-Cerda M, Cabrera-Miranda LA, Cardona AF, de la Garza JG, Rosell R. Arrieta O, et al. Among authors: de la garza jg. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1442-1450. doi: 10.1016/j.ijrobp.2021.02.044. Epub 2021 Feb 25. Int J Radiat Oncol Biol Phys. 2021. PMID: 33640422 Clinical Trial.
High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
Arrieta O, Gallardo-Rincón D, Villarreal-Garza C, Michel RM, Astorga-Ramos AM, Martínez-Barrera L, de la Garza J. Arrieta O, et al. Among authors: de la garza j. J Thorac Oncol. 2009 Jul;4(7):845-52. doi: 10.1097/JTO.0b013e3181a97e17. J Thorac Oncol. 2009. PMID: 19487963 Free article.
Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.
Arrieta O, González-De la Rosa CH, Aréchaga-Ocampo E, Villanueva-Rodríguez G, Cerón-Lizárraga TL, Martínez-Barrera L, Vázquez-Manríquez ME, Ríos-Trejo MA, Alvarez-Avitia MA, Hernández-Pedro N, Rojas-Marín C, De la Garza J. Arrieta O, et al. Among authors: de la garza j. J Clin Oncol. 2010 Jul 20;28(21):3463-71. doi: 10.1200/JCO.2009.26.6452. Epub 2010 Jun 14. J Clin Oncol. 2010. PMID: 20547984 Clinical Trial.
Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation.
Arrieta O, Villarreal-Garza C, Zamora J, Blake-Cerda M, de la Mata MD, Zavala DG, Muñiz-Hernández S, de la Garza J. Arrieta O, et al. Among authors: de la garza j, de la mata md. Radiat Oncol. 2011 Nov 25;6:166. doi: 10.1186/1748-717X-6-166. Radiat Oncol. 2011. PMID: 22118497 Free PMC article.
Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study.
Arrieta O, Barrón F, Maldonado F, Cabrera L, Corona-Cruz JF, Blake M, Ramírez-Tirado LA, Zatarain-Barrón ZL, Cardona AF, García O, Arén O, De la Garza J. Arrieta O, et al. Among authors: de la garza j. Lung Cancer. 2019 Apr;130:67-75. doi: 10.1016/j.lungcan.2019.02.006. Epub 2019 Feb 7. Lung Cancer. 2019. PMID: 30885354 Clinical Trial.
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations.
Arrieta O, Catalán R, Guzmán-Vazquez S, Barrón F, Lara-Mejía L, Soto-Molina H, Ramos-Ramírez M, Flores-Estrada D, de la Garza J. Arrieta O, et al. Among authors: de la garza j. BMC Cancer. 2020 Sep 1;20(1):829. doi: 10.1186/s12885-020-07329-8. BMC Cancer. 2020. PMID: 32873256 Free PMC article.
Lung Cancer in Mexico.
Arrieta O, Zatarain-Barrón ZL, Aldaco F, Barrón F, Báez-Saldaña R, Campos-Gómez S, Trejo R, De la Garza J. Arrieta O, et al. Among authors: de la garza j. J Thorac Oncol. 2019 Oct;14(10):1695-1700. doi: 10.1016/j.jtho.2019.05.018. J Thorac Oncol. 2019. PMID: 31558229 Free article. No abstract available.
101 results